Gain Therapeutics OverviewGain Therapeutics Other Income Expense Net
Other Income/Expense Net for GANX.
Quarterly Other Income/Expense
-$72121.00
↓ 19.86% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$601227.00
↓ 1940.92% YoY
Trailing 12 months ending Mar 31, 2026